Fuva Brain Ltd. (JP:3927)

:3927

3927

Fuva Brain Ltd.

RESEARCH TOOLSreports

Want to see JP:3927 full AI Analyst Report?

Fuva Brain Ltd. (3927) Price & Analysis

0 Followers

3927 Stock Chart & Stats

¥810.00

-¥1.00(-0.15%)

At close: Jan 08 4:00 PM EST

¥810.00

-¥1.00(-0.15%)

Day’s Range― - ―

52-Week Range¥644.00 - ¥1,280.00

Previous CloseN/A

Volume26.10K

Average Volume (3M)98.91K

Market Cap

¥5.50B

Enterprise Value¥4.17B

Total Cash (Recent Filing)¥1.93B

Total Debt (Recent Filing)¥541.30M

Price to Earnings (P/E)23.5

Beta1.03

Next Earnings

May 15, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)8.44

Shares Outstanding5,604,200

10 Day Avg. Volume142,280

30 Day Avg. Volume98,910

Financial Highlights & Ratios

PEG Ratio0.11

Price to Book (P/B)2.32

Price to Sales (P/S)0.82

P/FCF Ratio41.50

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Sustained Revenue GrowthMulti-year top-line scaling demonstrates durable market traction and product adoption. Growing revenue enlarges addressable market share, supports investment in R&D and sales, and increases upside for operating leverage if cost structure stabilizes over the next several quarters.

Return To Profitability And Improved ROEConsistent profitability and rising ROE reflect improved capital efficiency and execution versus prior loss years. This creates durable capacity to reinvest earnings, support product development and strategic initiatives, and reduces reliance on external funding if maintained.

Relatively Healthy Balance SheetA solid equity base and moderate leverage provide a financial buffer to absorb shocks and finance growth. Asset expansion alongside revenue supports scaling operations and offers flexibility to fund working capital or targeted investments without immediate distress.

Bears Say

Margin CompressionMaterial decline in gross and net margins reduces the earnings cushion and makes profitability highly sensitive to cost inflation or pricing pressure. Thin net margins limit free cash flow potential and increase downside risk if revenue growth slows in the medium term.

Weaker And Volatile Cash GenerationA marked drop in OCF and a history of volatile cash flows hinder the company's ability to self-fund operations and investments. With inconsistent cash conversion, management may need recurring external financing, raising execution and refinancing risk over the next 2–6 months.

Rising Leverage In 2025A notable rise in absolute debt heightens interest and refinancing obligations at a time of thin margins and weaker cash flow. Increased leverage reduces financial flexibility and elevates downside risk if revenue growth or cash conversion deteriorates further.

3927 FAQ

What was Fuva Brain Ltd.’s price range in the past 12 months?

Fuva Brain Ltd. lowest stock price was ¥644.00 and its highest was ¥1280.00 in the past 12 months.

What is Fuva Brain Ltd.’s market cap?

Fuva Brain Ltd.’s market cap is ¥5.50B.

When is Fuva Brain Ltd.’s upcoming earnings report date?

Fuva Brain Ltd.’s upcoming earnings report date is May 15, 2026 which is in 19 days.

How were Fuva Brain Ltd.’s earnings last quarter?

Fuva Brain Ltd. released its earnings results on Feb 18, 2026. The company reported ¥8.44 earnings per share for the quarter, beating the consensus estimate of N/A by ¥8.44.

Is Fuva Brain Ltd. overvalued?

According to Wall Street analysts Fuva Brain Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Fuva Brain Ltd. pay dividends?

Fuva Brain Ltd. pays a Notavailable dividend of ¥15 which represents an annual dividend yield of N/A. See more information on Fuva Brain Ltd. dividends here

What is Fuva Brain Ltd.’s EPS estimate?

Fuva Brain Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Fuva Brain Ltd. have?

Fuva Brain Ltd. has 5,604,200 shares outstanding.

What happened to Fuva Brain Ltd.’s price movement after its last earnings report?

Fuva Brain Ltd. reported an EPS of ¥8.44 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.202%.

Which hedge fund is a major shareholder of Fuva Brain Ltd.?

Currently, no hedge funds are holding shares in JP:3927

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Fuva Brain Ltd.

Fuva Brain Limited engages in the development and sale of cyber security solutions in Japan. The company offers gateway network, endpoint security, internal fraud countermeasures, and productivity improvement solutions. It provides Eye "247" Work Smart for supporting productivity improvement for business visualization analysis and information leakage countermeasures; Eye "247" Work Smart Server, a model file server for small and medium-sized businesses; Eye "247" AntiMalware for protection against known, subspecies, and unknown threats; SecureSphere, integrated security solution for web applications and database servers; and Incapsula for cloud-based web security. The company was formerly known as Ahkun Co., Ltd. and changed its name to Fuva Brain Limited in October 2018. Fuva Brain Limited was incorporated in 2001 and is based in Tokyo, Japan.